Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. On123300
1. 1357470-29-1
2. On123300
3. On-123300
4. Narazaciclib
5. Qj8ro3296g
6. Chembl3115681
7. Pyrido(2,3-d)pyrimidine-6-carbonitrile, 8-cyclopentyl-7,8-dihydro-2-((4-(4-methyl-1-piperazinyl)phenyl)amino)-7-oxo-
8. 8-cyclopentyl-2-[4-(4-methylpiperazin-1-yl)anilino]-7-oxopyrido[2,3-d]pyrimidine-6-carbonitrile
9. Unii-qj8ro3296g
10. On 123300
11. Narazaciclib [inn]
12. Schembl10050883
13. Gtpl11879
14. Bcp19186
15. Ex-a1111
16. Bdbm50447512
17. Mfcd28411414
18. Nsc802100
19. S8161
20. Akos030526450
21. Zinc103269269
22. Ccg-268995
23. Cs-5570
24. Nsc-802100
25. Sb16989
26. Compound 7x [pmid: 24417566]
27. Ac-35541
28. As-35286
29. Hy-12624
30. Db-100781
31. A857300
32. Q27287291
33. 8-cyclopentyl-2-((4-(4-methylpiperazin-1-yl)phenyl)amino)-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidine-6-carbonitrile;on 123300
34. 8-cyclopentyl-2-[4-(4-methyl-piperazine-1-yl)-phenylamino]-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidine-6-carbonitrile
Molecular Weight | 429.5 g/mol |
---|---|
Molecular Formula | C24H27N7O |
XLogP3 | 3.1 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 4 |
Exact Mass | 429.22770851 g/mol |
Monoisotopic Mass | 429.22770851 g/mol |
Topological Polar Surface Area | 88.4 Ų |
Heavy Atom Count | 32 |
Formal Charge | 0 |
Complexity | 754 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
45
PharmaCompass offers a list of Narazaciclib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Narazaciclib manufacturer or Narazaciclib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Narazaciclib manufacturer or Narazaciclib supplier.
PharmaCompass also assists you with knowing the Narazaciclib API Price utilized in the formulation of products. Narazaciclib API Price is not always fixed or binding as the Narazaciclib Price is obtained through a variety of data sources. The Narazaciclib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Narazaciclib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Narazaciclib, including repackagers and relabelers. The FDA regulates Narazaciclib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Narazaciclib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Narazaciclib supplier is an individual or a company that provides Narazaciclib active pharmaceutical ingredient (API) or Narazaciclib finished formulations upon request. The Narazaciclib suppliers may include Narazaciclib API manufacturers, exporters, distributors and traders.
Narazaciclib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Narazaciclib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Narazaciclib GMP manufacturer or Narazaciclib GMP API supplier for your needs.
A Narazaciclib CoA (Certificate of Analysis) is a formal document that attests to Narazaciclib's compliance with Narazaciclib specifications and serves as a tool for batch-level quality control.
Narazaciclib CoA mostly includes findings from lab analyses of a specific batch. For each Narazaciclib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Narazaciclib may be tested according to a variety of international standards, such as European Pharmacopoeia (Narazaciclib EP), Narazaciclib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Narazaciclib USP).